Cotinga Pharmaceuticals Inc. (COT.V) (COT) News Today → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free COT Stock Alerts C$0.04 -0.03 (-41.67%) (As of 10/14/2020) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLexicon Pharmaceuticals Inc.wsj.com - February 14 at 2:28 PMAcumen Pharmaceuticals Inc ABOSmorningstar.com - November 5 at 5:44 AMSXTP 60 Degrees Pharmaceuticals, Inc.seekingalpha.com - July 22 at 12:42 AM8-K: ENANTA PHARMACEUTICALS INCmarketwatch.com - April 28 at 8:42 AMIronwood Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 18 at 2:25 PMPTPI Petros Pharmaceuticals, Inc.seekingalpha.com - January 24 at 12:37 PMAmylyx Pharmaceuticals Inc.wsj.com - October 11 at 1:58 PMPepGen Reports Second Quarter 2022 Financial Results and Recent Corporate Developmentsyahoo.com - August 12 at 8:43 AMExagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conferencefinance.yahoo.com - May 26 at 4:14 PM Get Cotinga Pharmaceuticals Inc. (COT.V) News Delivered to You Automatically Sign up to receive the latest news and ratings for COT and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better. Click here to find out that this 8,788% cryptocurrency is. COT Media Mentions By Week COT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COT News Sentiment▼0.000.61▲Average Medical News Sentiment COT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COT Articles This Week▼00▲COT Articles Average Week Get Cotinga Pharmaceuticals Inc. (COT.V) News Delivered to You Automatically Sign up to receive the latest news and ratings for COT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BTI News SVS News IOT News IDL News VIV News KO News EKG News AQS News QPT News HEM News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:COT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cotinga Pharmaceuticals Inc. (COT.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.